Semaglutide Oral Tablets

Semaglutide Oral Tablets is a research-grade formulation containing a synthetic analog of human glucagon-like peptide-1 (GLP-1) in solid oral dosage form, designed for laboratory investigation of incretin hormone pathways and oral peptide delivery mechanisms. This peptide is classified as a GLP-1 receptor agonist and is utilized in preclinical research examining metabolic regulation, gastrointestinal absorption enhancement, and oral bioavailability of therapeutic peptides. Semaglutide is a modified GLP-1 analog engineered with structural modifications to enhance stability, combined with absorption enhancers to facilitate oral delivery in experimental models. This product is formulated as research-grade tablets incorporating peptide stabilization and permeation enhancement technologies for controlled oral administration studies and is intended solely for scientific research purposes and is not for human or veterinary use.